Starboard vs. Bristol-Myers Squibb: Who'll Win This Brewing Battle?
An activist investor made a strong argument for walking away from Celgene, but will investors listen?...
Related Articles
- Public Companies' Public Enemies also published in Fool.com
- Is Your Board Meeting Location a Distraction? by Susan Hammond also categorized in BoardBlogs
- Hewlett-Packard Shakes Up Management, Raises Outlook also mentions Management
- Who’s in charge here? By: Charles Whipple also categorized in BoardBlogs
- Great Advice for Board Candidates (and Boards) By: Mark Rogers also categorized in BoardBlogs
- The 70:20:10 Rule of Board Learning by Debra Beck also categorized in BoardBlogs
- Everyone Gets Rated By Leigh Tucker also categorized in BoardBlogs
- Are You Ready for an Advisory Board? Twelve Questions to Help You Decide By: Susan Hammond also categorized in BoardBlogs
- 3 AIM Shares With Good Corporate Governance: Part 1 also published in Fool.com
- The Men Who Run Glencore also published in Fool.com
Login to comment.